Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,778 | -14,617 | -29,359 | -26,925 | -9,240 |
| Depreciation Amortization | 1,888 | 1,484 | 1,333 | 557 | 417 |
| Accounts receivable | 108 | 317 | 806 | -895 | -988 |
| Other Working Capital | -1,401 | -1,054 | 2,647 | 784 | -305 |
| Other Operating Activity | 400 | -3,611 | 4,311 | 13,658 | 988 |
| Operating Cash Flow | $-23,782 | $-17,481 | $-20,263 | $-12,822 | $-9,129 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 22,371 | -13,420 | 832 | -8,115 | N/A |
| PPE Investments | -1,070 | -1,640 | -2,778 | -4,177 | -813 |
| Purchase Sale Intangibles | -463 | -397 | -453 | -476 | -283 |
| Other Investing Activity | -463 | -397 | -453 | -476 | -283 |
| Investing Cash Flow | $20,838 | $-15,457 | $-2,399 | $-12,768 | $-1,096 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,074 | 35,077 | 21,978 | 10,761 | 27,440 |
| Financing Cash Flow | $7,074 | $35,077 | $21,978 | $10,761 | $27,440 |
| Beginning Cash Position | 12,525 | 10,385 | 11,070 | 25,899 | 8,683 |
| End Cash Position | 16,655 | 12,525 | 10,385 | 11,070 | 25,899 |
| Net Cash Flow | $4,130 | $2,140 | $-685 | $-14,829 | $17,216 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,782 | -17,481 | -20,263 | -12,822 | -9,129 |
| Capital Expenditure | -1,070 | -1,640 | -2,778 | -4,177 | -813 |
| Free Cash Flow | -24,852 | -19,121 | -23,041 | -17,000 | -9,942 |